Randomised, double-blind, placebo-controlled trial of fructo-oligosaccharides in active Crohn's disease - Benjamin, Jane L; Hedin, Charlotte R H; Koutsoumpas, Andreas; Ng, Siew C; McCarthy, Neil E; Hart, Ailsa L; Kamm, Michael A; Sanderson, Jeremy D; Knight, Stella C; Forbes, Alastair; Stagg, Andrew J; Whelan, Kevin; et al. (Gut, 2011)
Keywords: Adult; Bifidobacterium - isolation & purification; Biological and medical sciences; Biomedical research; Carbohydrates; clinical trials; Crohn Disease - drug therapy; Crohn Disease - immunology; Crohn Disease - microbiology; Crohn's disease; Cytokines; Dendritic cells; Dendritic Cells - immunology; Double-Blind Method; Endoscopy; Faecalibacterium prausnitzii; Feces - microbiology; Female; Fermentation; Fructo-oligosaccharide; Gastroenterology. Liver. Pancreas. Abdomen; Humans; Immunity, Mucosal; Immunology; Inflammation; Inflammatory bowel disease; Intestinal Mucosa - immunology; inulin; Male; Medical sciences; Medication Adherence; Middle Aged; molecular immunology; oligofructose; Oligosaccharides - adverse effects; Oligosaccharides - therapeutic use; Other diseases. Semiology; prebiotic; Prebiotics; Prebiotics - adverse effects; Probiotics; Rectum - immunology; Rodents; Stomach. Duodenum. Small intestine. Colon. Rectum. Anus; Studies; Treatment Outcome; University colleges; Crohn disease; Digestive diseases; Intestinal disease; Gastroenterology; Inflammatory disease